Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges-Reference-Cited by-同舟云学术

Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges

Published:2023-04-26 Issue:6 Volume:24 Page:693-710
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Olivi Matteo,Di Biase Federica,Lanzarone Giuseppe,Arrigo Giulia,Martella Federica,Apolito Vincenzo,Secreto Carolina,Freilone Roberto,Bruno Benedetto,Audisio Ernesta,Ferrero Dario,Beggiato Eloise,Cerrano Marco

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11864-023-01089-w.pdf

Reference97 articles.

1. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125(6):490–3.

2. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632–4.

3. Falanga A, Russo L, Verzeroli C. Mechanisms of thrombosis in cancer. Thromb Res. 2013;131(Suppl):S59-62.

4. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110(10):2339–46.

5. Kuderer NM, Francis CW, Culakova E, Khorana AA, Ortel T, Falanga A, et al. Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy. J Clin Oncol [Internet]. 2008;26(15\_suppl):9521. Available from: https://doi.org/10.1200/jco.2008.26.15_suppl.9521.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies;International Journal of Molecular Sciences;2024-06-08

2. Acute pulmonary embolism in cancer patients admitted to intensive care unit: Impact of anticoagulant treatment on 90-day mortality and risk factors, results of a multicentre retrospective study;Thrombosis Research;2024-05

3. Thrombosis in Myeloid Malignancies: From CHIP to AML;Cardiovascular & Hematological Disorders-Drug Targets;2024-03

4. Cerebral venous thrombosis as a first presentation of a high-risk acute myeloid leukaemia;Acta Neurologica Belgica;2023-12-27

5. Targeting SDCBP2 in acute myeloid leukemia;Cellular Signalling;2023-12